These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4017162)

  • 41. [Phase II study of 4'-O-tetrahydropyranyladriamycin(THP-ADM)].
    Nakada H; Ogawa M; Miyamoto H; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Usui N; Adachi K; Okada Y
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):138-42. PubMed ID: 6696455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
    Maniez-Devos DM; Baurain R; Lesne M; Trouet A
    J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Shock wave therapy of the rabbit VX2 bladder cancer--THP-ADM concentration in the tissue after combination therapy of THP-ADM and shock wave].
    Suzuki K; Orikasa S; Hoshi S; Kuwahara M; Yoshikawa K; Ohyama C; Satou M; Kawamura S
    Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1007-12. PubMed ID: 8345717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to alloxan-induced diabetes mellitus rats.
    Lee HJ; Paik WH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):165-78. PubMed ID: 8556271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular uptake and efflux and cytostatic activity of 4'-O-tetrahydropyranyladriamycin in adriamycin-sensitive and resistant tumor cell lines.
    Kunimoto S; Miura K; Umezawa K; Xu CZ; Masuda T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1984 Dec; 37(12):1697-702. PubMed ID: 6526737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of adriamycin and adriamycinol after intravenous administration of adriamycin to rats with water-deprivation for 48 hours.
    Lee HJ; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):299-306. PubMed ID: 9261889
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS).
    Cummings J; Merry S; Willmott N
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):451-60. PubMed ID: 3460809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epirubicin plasma and blood pharmacokinetics after single i.v. bolus in advanced cancer patients.
    Camaggi CM; Strocchi E; Martoni A; Angelelli B; Comparsi R; Pannuti F
    Drugs Exp Clin Res; 1985; 11(4):285-94. PubMed ID: 3869807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sonodynamically induced cell damage with 4'-O-tetrahydropyranyladriamycin, THP.
    Yumita N; Kaneuchi M; Okano Y; Nishigaki R; Umemura K; Umemura S
    Anticancer Res; 1999; 19(1A):281-4. PubMed ID: 10226555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis and pharmacokinetics of N-l-leucyldoxorubucin and metabolites in tissues of tumor-bearing BALB/c mice.
    de Jong J; Klein I; Bast A; van der Vijgh WJ
    Cancer Chemother Pharmacol; 1992; 31(2):156-60. PubMed ID: 1451235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue distribution and antitumor effect of liposome-entrapped doxorubicin (adriamycin) in Ehrlich solid tumor-bearing mouse.
    Shinozawa S; Araki Y; Oda T
    Acta Med Okayama; 1981 Dec; 35(6):395-405. PubMed ID: 6459710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antitumor activity of (2''R)-4'-O-tetrahydropyranyl adriamycin on human gastric cancer cell lines in vitro and in vivo.
    Saikawa Y; Kubota T; Kuo TH; Furukawa T; Kase S; Tanino H; Ishibiki K; Kitajima M; Hoffman RM
    Anticancer Res; 1994; 14(2A):469-73. PubMed ID: 8017850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [THP-adriamycin in head and neck tumor].
    Honda T; Ohyama W; Sonoda T; Uchida K; Hirokawa T; Takada K; Takeda C
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2538-44. PubMed ID: 6651307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation between nuclear action of anthracycline anticancer agents and their binding affinity to the proteasome.
    Kiyomiya K; Satoh J; Horie H; Kurebe M; Nakagawa H; Matsuo S
    Int J Oncol; 2002 Nov; 21(5):1081-5. PubMed ID: 12370758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and metabolism of pirarubicin in advanced cancer patients.
    Robert J; David M; Huet S; Chauvergne J
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1289-94. PubMed ID: 3181250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative cardiotoxicity and antitumour activity of doxorubicin (adriamycin) and 4'-deoxydoxorubicin and the relationship to in vivo disposition and metabolism in the target tissues.
    Cummings J; Willmott N; More I; Kerr DJ; Morrison JG; Kaye SB
    Biochem Pharmacol; 1987 May; 36(9):1521-6. PubMed ID: 3579988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Time dependency of adriamycin and adriamycinol kinetics.
    Gil P; Favre R; Durand A; Iliadis A; Cano JP; Carcassonne Y
    Cancer Chemother Pharmacol; 1983; 10(2):120-4. PubMed ID: 6831625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
    Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrate-induced acute renal failure rats.
    Lee HJ; Paik WH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):195-204. PubMed ID: 8832911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of the concentration of adriamycin and its metabolites in the serum and tissues of Ehrlich carcinoma-bearing mice by high-performance liquid chromatography.
    Shinozawa S; Mimaki Y; Araki Y; Oda T
    J Chromatogr; 1980 Aug; 196(3):463-9. PubMed ID: 7430305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.